Announced Tue, 5 Aug · 12:16 IST

Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the following business: 1. ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Chemo Pharma Laboratories Ltd has informed BSE that its Board of Directors will meet on Tuesday, August 12, 2025 at 4:00 p.m. at the registered office in Kalyan, Thane. Key items on the agenda include approval of un-audited financial results for Q1 FY26 (quarter ended June 30, 2025), the notice for the 83rd Annual General Meeting, and fixing the book closure and record date for the AGM. Importantly, the board will also consider a proposal to change the company's name, alter the main object clause of the Memorandum of Association, and shift the registered office from Maharashtra to Gujarat. The trading window for insiders has been closed since July 1, 2025 and will reopen 48 hours after the Q1 results are announced.

Likely market impact

Multiple significant proposals on the table — Q1 earnings will set the near-term performance tone, while the proposed name change and interstate shift of registered office signal a possible strategic repositioning. Shareholders should watch these non-routine items as they could materially affect the company's identity and operations once approved.